It was previously reported that the neuroprotective action of losartan after cerebral ischemia/reperfusion injury involved inhibition of the AT1/ASK1/MKK4/JNK3 pathway in the hippocampal CA1 region (30). The gene discussed is MAP3K5; the disease is Cerebral ischemia.